Non-type 2 inflammation in severe asthma is propelled by neutrophil cytoplasts and maintained by defective resolution
Open Access
- 1 April 2019
- journal article
- review article
- Published by Elsevier in Allergology International
- Vol. 68 (2) , 143-149
Abstract
No abstract availableKeywords
Funding Information
- NIH (RO1-HL122531, K12-HD047349)
This publication has 48 references indexed in Scilit:
- Exhaled breath condensate eicosanoid levels associate with asthma and its severityJournal of Allergy and Clinical Immunology, 2013
- Annexin A1 Interaction with the FPR2/ALX ReceptorJournal of Biological Chemistry, 2012
- Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAsThe American Journal of Pathology, 2012
- Serum amyloid A opposes lipoxin A4to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary diseaseProceedings of the National Academy of Sciences, 2012
- Urinary concentrations of 15‐epimer of lipoxin A4are lower in patients with aspirin‐intolerant compared with aspirin‐tolerant asthmaClinical & Experimental Allergy, 2011
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Resolvin D1 binds human phagocytes with evidence for proresolving receptorsProceedings of the National Academy of Sciences, 2010
- Airway Lipoxin A4 Generation and Lipoxin A4 Receptor Expression Are Decreased in Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Novel cell death program leads to neutrophil extracellular trapsJournal of Cell Biology, 2007